Company · CIK 0001439222 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
AGIOS PHARMACEUTICALS, INC. · AGIO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2015 SForm 4 → | Mar 9, 6:41 pm EDT | David P SchenkeinChief Executive Officer, Director | 2,600 | $110.16 | $286,416 | 102,501 | −2.47% | plan? |
| Mar 2, 2015 SForm 4 → | Mar 3, 5:18 pm EST | David P SchenkeinChief Executive Officer, Director | 7,800 | $107.05 | $834,990 | 105,101 | −6.91% | plan? |
| Feb 27, 2015 AForm 4 → | Mar 3, 5:22 pm EST | Scott BillerChief Scientific Officer | 270 | $39.35 | $10,625 | 42,770 | — | plan? |
| Feb 27, 2015 MForm 4 → | Mar 3, 5:18 pm EST | David P SchenkeinChief Executive Officer, Director | 25,000 | $0.3025 | $7,563 | 248,272 | — | plan? |
| Feb 19, 2015 JForm 4 → | Feb 23, 4:56 pm EST | Arch Venture Fund VII LP +410% Owner | 386,074 | — | — | 3,088,590 | — | plan? |
| Feb 19, 2015 JForm 4 → | Feb 23, 4:38 pm EST | Robert NelsenDirector | 388,304 | — | — | 4,460 | — | plan? |
| Feb 19, 2015 JForm 4 → | Feb 19, 7:03 pm EST | THIRD ROCK VENTURES LP +210% Owner | 4,590,480 | — | — | 0 | — | plan? |
| Feb 19, 2015 JForm 4 → | Feb 19, 7:01 pm EST | Kevin P StarrDirector, 10% Owner | 4,748,347 | — | — | 184,386 | — | plan? |
| Feb 13, 2015 SForm 4 → | Feb 17, 5:20 pm EST | Glenn GoddardSenior Vice President, Finance | 1,316 | $120.31 | $158,328 | 0 | −100% | plan? |
| Feb 13, 2015 MForm 4 → | Feb 17, 5:20 pm EST | Glenn GoddardSenior Vice President, Finance | 1,316 | $23.10 | $30,400 | 1,316 | — | plan? |
| Feb 11, 2015 SForm 4 → | Feb 13, 5:39 pm EST | David P SchenkeinChief Executive Officer, Director | 1,471 | $120.22 | $176,842 | 106,401 | −1.36% | plan? |
| Feb 9, 2015 SForm 4 → | Feb 11, 6:22 pm EST | Glenn GoddardSenior Vice President, Finance | 16,513 | $107.12 | $1,768,922 | 0 | −100% | plan? |
| Feb 9, 2015 MForm 4 → | Feb 11, 6:22 pm EST | Glenn GoddardSenior Vice President, Finance | 16,513 | $22.18 | $366,187 | 1,513 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 3, 6:34 pm EST | David P SchenkeinChief Executive Officer, Director | 10,400 | $114.31 | $1,188,824 | 107,872 | −8.79% | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 5:36 pm EST | Scott BillerChief Scientific Officer | 4,500 | $110.08 | $495,360 | 42,500 | −9.57% | plan? |
| Jan 2, 2015 MForm 4 → | Jan 6, 5:36 pm EST | Scott BillerChief Scientific Officer | 4,500 | $0.4675 | $2,104 | 47,000 | — | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 5:26 pm EST | David P SchenkeinChief Executive Officer, Director | 13,000 | $110.08 | $1,431,040 | 111,772 | −10.4% | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 5:23 pm EST | John Duncan HiggonsChief Operating Officer | 12,000 | $110.08 | $1,320,960 | 119,835 | −9.10% | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 5:22 pm EST | John Duncan HiggonsChief Operating Officer | 12,000 | $110.08 | $1,320,960 | 119,835 | −9.10% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2015 AForm 4 → | Jun 25, 7:51 pm EDT | Robert NelsenDirector | 10,625 | — | — | 23,125 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 6:28 pm EDT | Marc Tessier-LavigneDirector | 11,262 | — | — | 40,375 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 6:27 pm EDT | John MaraganoreDirector | 10,625 | — | — | 33,125 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 6:26 pm EDT | Perry A KarsenDirector | 10,625 | — | — | 23,125 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 6:25 pm EDT | Kaye I Foster-CheekDirector | 11,899 | — | — | 36,899 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 6:25 pm EDT | Douglas G. ColeDirector | 10,625 | — | — | 23,125 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 6:23 pm EDT | Paul J ClancyDirector | 11,900 | — | — | 49,400 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 6:22 pm EDT | Lewis Clayton Cantley Jr.Director | 10,625 | — | — | 168,579 | — | |
| Jun 23, 2015 AForm 4 → | Jun 25, 6:22 pm EDT | Scott BillerChief Scientific Officer | 12,363 | — | — | 314,880 | — | |
| Jun 16, 2015 MForm 4 → | Jun 17, 6:28 pm EDT | Scott BillerChief Scientific Officer | 300 | — | — | 302,517 | — | |
| Jun 10, 2015 MForm 4 → | Jun 12, 4:53 pm EDT | John Duncan HiggonsChief Operating Officer | 30,000 | — | — | 335,022 | — | |
| Jun 1, 2015 MForm 4 → | Jun 2, 6:19 pm EDT | Christopher BowdenChief Medical Officer | 5,000 | — | — | 132,000 | — | |
| May 27, 2015 MForm 4 → | May 28, 5:30 pm EDT | Glenn GoddardSenior Vice President, Finance | 2,171 | — | — | 109,098 | — | |
| May 7, 2015 MForm 4 → | May 11, 5:14 pm EDT | David P SchenkeinChief Executive Officer, Director | 10,000 | — | — | 879,320 | — | |
| Mar 16, 2015 MForm 4 → | Mar 18, 5:17 pm EDT | Glenn GoddardSenior Vice President, Finance | 10,000 | — | — | 111,269 | — | |
| Mar 16, 2015 MForm 4 → | Mar 18, 5:15 pm EDT | Scott BillerChief Scientific Officer | 5,500 | — | — | 302,817 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 5:22 pm EST | Scott BillerChief Scientific Officer | 68,000 | — | — | 308,317 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 5:21 pm EST | Glenn GoddardSenior Vice President, Finance | 30,600 | — | — | 121,269 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 5:20 pm EST | John Duncan HiggonsChief Operating Officer | 68,000 | — | — | 365,022 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 5:19 pm EST | Christopher BowdenChief Medical Officer | 17,000 | — | — | 137,000 | — | |
| Feb 27, 2015 AMForm 4 → | Mar 3, 5:18 pm EST | David P SchenkeinChief Executive Officer, Director | 161,000 | — | — | 889,320 | — | |
| Feb 13, 2015 MForm 4 → | Feb 17, 5:20 pm EST | Glenn GoddardSenior Vice President, Finance | 1,316 | — | — | 90,669 | — | |
| Feb 9, 2015 MForm 4 → | Feb 11, 6:22 pm EST | Glenn GoddardSenior Vice President, Finance | 16,513 | — | — | 91,985 | — | |
| Jan 2, 2015 MForm 4 → | Jan 6, 5:36 pm EST | Scott BillerChief Scientific Officer | 4,500 | $0.4675 | $2,104 | 240,317 | — |